HIV-1 DNA burden dynamics in CD4 T cells and monocytes in patients undergoing a transient therapy interruption

被引:15
作者
Garbuglia, AR
Calcaterra, S
D'Offizi, G
Topino, S
Narciso, P
Lillo, F
Girardi, E
Capobianchi, MR
机构
[1] IRCCS, Natl Inst Infect Dis L Spallanzani, Virol Lab, I-00149 Rome, Italy
[2] Hosp San Raffaele, IRCCS, Virol Lab, I-20132 Milan, Italy
关键词
TTI; HIV-1 DNA burden; ART; HIV-1; reservoir;
D O I
10.1002/jmv.20188
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Replication-competent HIV, as well as HIV-1 DNA, has been detected in CD4 T cells and in monocytes during antiretroviral therapy (ART), indicating that these cells could represent an important viral reservoir. We measured HIV-1 DNA in monocytes and CD4 T cells in patients undergoing transient therapy interruption (TTI), to establish the dynamic of HIV-1 DNA burden and to find possible correlations with immune restoration and re-establishment of virological control after ART resumption. In most patients CD4 depletion and viral load rebound followed TTI. Rapid resumption of virological and immunological control was achieved after ART reintroduction. After TTI, in most cases a transient increase of both monocyte and CD4 HIV-1 DNA burden was observed. After ART reintroduction, both CD4 T cell and monocyte HIV-1 DNA copy number decreased, reaching baseline levels at the end of observation. At this time monocyte HIV-1 DNA burden was always undetectable, while CD4T cell HIV-1 DNA burden was lower than at baseline. As CD4 T cell HIV-1 DNA values are independently associated with CD4 depletion, the increase of HIV-1 DNA burden in these cells after TTI is presumably due to acute infection, causing cell death. This is also supported by the pattern of 2-LTR appearance in these cells after TTI. HIV-1 DNA burden in monocytes and CD4 T cells show high correlation, suggesting reciprocal re-feeding of two cell populations. Repopulation by HIV these cells after TTI is temporary, and no significant changes of HIV-1 DNA burden were observed after ART resumption respect to pre-TTI period. (C) 2004 Wiley-Liss, Inc.
引用
收藏
页码:373 / 381
页数:9
相关论文
共 38 条
[1]   Changes in host cell molecules acquired by circulating HIV-1 in patients treated with highly active antiretroviral therapy and interleukin-2 [J].
Abbate, I ;
Dianzani, F ;
Turriziani, O ;
Antonelli, G ;
D'Offizi, C ;
Galati, V ;
Pierdominici, M ;
Pandolfi, F ;
Capobianchi, MR .
AIDS, 2001, 15 (01) :11-16
[2]   Drug resistance at low viraemia in HIV-1-infected patients with antiretroviral combination therapy [J].
Aleman, S ;
Söderbärg, K ;
Visco-Comandini, U ;
Sitbon, G ;
Sönnerborg, A .
AIDS, 2002, 16 (07) :1039-1044
[3]   Comparative analysis of total and integrated HIV-1 DNA in peripheral CD4 lymphocytes and monocytes after long treatment with HAART [J].
Calcaterra, S ;
Cappiello, G ;
Di Caro, A ;
Garbuglia, AR ;
Benedetto, A .
JOURNAL OF INFECTION, 2001, 43 (04) :239-245
[4]   A syndrome of peripheral lipodystrophy, hyperlipidaemia and insulin resistance in patients receiving HIV protease inhibitors [J].
Carr, A ;
Samaras, K ;
Burton, S ;
Law, M ;
Freund, J ;
Chisholm, DJ ;
Cooper, DA .
AIDS, 1998, 12 (07) :F51-F58
[5]   Presence of an inducible HIV-1 latent reservoir during highly active antiretroviral therapy [J].
Chun, TW ;
Stuyver, L ;
Mizell, SB ;
Ehler, LA ;
Mican, JAM ;
Baseler, M ;
Lloyd, AL ;
Nowak, MA ;
Fauci, AS .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (24) :13193-13197
[6]   Virologic and immunologic consequences of discontinuing combination antiretroviral-drug therapy in HIV-infected patients with detectable viremia. [J].
Deeks, SG ;
Wrin, T ;
Liegler, T ;
Hoh, R ;
Hayden, M ;
Barbour, JD ;
Hellmann, NS ;
Petropoulos, CJ ;
McCune, JM ;
Hellerstein, MK ;
Grant, RM .
NEW ENGLAND JOURNAL OF MEDICINE, 2001, 344 (07) :472-480
[7]   Genetic characterization of rebounding human immunodeficiency virus type 1 in plasma during multiple interruptions of highly active antiretroviral therapy [J].
Dybul, M ;
Daucher, M ;
Jensen, MA ;
Hallahan, CW ;
Chun, TW ;
Belson, M ;
Hidalgo, B ;
Nickle, DC ;
Yoder, C ;
Metcalf, JA ;
Davey, RT ;
Ehler, L ;
Kress-Rock, D ;
Nies-Kraske, E ;
Liu, SY ;
Mullins, JI ;
Fauci, AS .
JOURNAL OF VIROLOGY, 2003, 77 (05) :3229-3237
[8]  
Elbeik T, 2001, J HUMAN VIROL, V4, P317
[9]   Latent infection of CD4+ T cells provides a mechanism for lifelong persistence of HIV-1, even in patients on effective combination therapy [J].
Finzi, D ;
Blankson, J ;
Siliciano, JD ;
Margolick, JB ;
Chadwick, K ;
Pierson, T ;
Smith, K ;
Lisziewicz, J ;
Lori, F ;
Flexner, C ;
Quinn, TC ;
Chaisson, RE ;
Rosenberg, E ;
Walker, B ;
Gange, S ;
Gallant, J ;
Siliciano, RF .
NATURE MEDICINE, 1999, 5 (05) :512-517
[10]   Identification of a reservoir for HIV-1 in patients on highly active antiretroviral therapy [J].
Finzi, D ;
Hermankova, M ;
Pierson, T ;
Carruth, LM ;
Buck, C ;
Chaisson, RE ;
Quinn, TC ;
Chadwick, K ;
Margolick, J ;
Brookmeyer, R ;
Gallant, J ;
Markowitz, M ;
Ho, DD ;
Richman, DD ;
Siliciano, RF .
SCIENCE, 1997, 278 (5341) :1295-1300